Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 63

1.

Dapagliflozin: Glucuretic action and beyond.

Balakumar P, Sundram K, Dhanaraj SA.

Pharmacol Res. 2014 Apr 3. pii: S1043-6618(14)00037-1. doi: 10.1016/j.phrs.2014.03.008. [Epub ahead of print] Review.

PMID:
24705156
[PubMed - as supplied by publisher]
2.

Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats.

Sharma AK, Khanna D, Balakumar P.

Int J Cardiol. 2014 Mar 15;172(2):530-2. doi: 10.1016/j.ijcard.2014.01.053. Epub 2014 Jan 23. No abstract available.

PMID:
24495652
[PubMed - in process]
3.

Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.

Bhardwaj P, Khanna D, Balakumar P.

Cardiovasc Toxicol. 2014 Mar;14(1):41-51. doi: 10.1007/s12012-013-9226-y.

PMID:
24048981
[PubMed - in process]
5.

Cardiovascular pleiotropic actions of DPP-4 inhibitors: a step at the cutting edge in understanding their additional therapeutic potentials.

Balakumar P, Dhanaraj SA.

Cell Signal. 2013 Sep;25(9):1799-803. doi: 10.1016/j.cellsig.2013.05.009. Epub 2013 May 22. Review.

PMID:
23707531
[PubMed - indexed for MEDLINE]
6.

Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.

Babbar L, Mahadevan N, Balakumar P.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):319-29. doi: 10.1007/s00210-012-0830-3. Epub 2013 Jan 17.

PMID:
23325365
[PubMed - indexed for MEDLINE]
7.

Biomedical research - from ideation to publication.

Balakumar P.

J Nat Sci Biol Med. 2012 Jul;3(2):212. doi: 10.4103/0976-9668.101938. No abstract available.

PMID:
23225992
[PubMed]
Free PMC Article
8.

Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.

Taneja G, Mahadevan N, Balakumar P.

Cardiovasc Toxicol. 2013 Jun;13(2):110-22. doi: 10.1007/s12012-012-9190-y.

PMID:
23208382
[PubMed - indexed for MEDLINE]
9.

Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.

Kathuria S, Mahadevan N, Balakumar P.

Mol Cell Biochem. 2013 Feb;374(1-2):61-72. doi: 10.1007/s11010-012-1505-6. Epub 2012 Nov 10.

PMID:
23149826
[PubMed - indexed for MEDLINE]
10.

Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.

Kadian S, Mahadevan N, Balakumar P.

Eur J Pharmacol. 2013 Jan 5;698(1-3):388-96. doi: 10.1016/j.ejphar.2012.10.012. Epub 2012 Oct 18.

PMID:
23085026
[PubMed - indexed for MEDLINE]
11.

Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors.

Sharma NK, Mahadevan N, Balakumar P.

Cardiovasc Toxicol. 2013 Mar;13(1):22-32. doi: 10.1007/s12012-012-9182-y.

PMID:
22948709
[PubMed - indexed for MEDLINE]
12.

The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.

Bishnoi HK, Mahadevan N, Balakumar P.

Pharmacol Res. 2012 Oct;66(4):349-56. doi: 10.1016/j.phrs.2012.07.001. Epub 2012 Jul 14.

PMID:
22796657
[PubMed - indexed for MEDLINE]
13.

The basic concepts of scientific research and scientific communication.

Balakumar P, Jagadeesh G.

J Pharmacol Pharmacother. 2012 Apr;3(2):178-82. doi: 10.4103/0976-500X.95522. No abstract available.

PMID:
22629094
[PubMed]
Free PMC Article
14.

Fish oil and vascular endothelial protection: bench to bedside.

Balakumar P, Taneja G.

Free Radic Biol Med. 2012 Jul 15;53(2):271-9. doi: 10.1016/j.freeradbiomed.2012.05.005. Epub 2012 May 12. Review.

PMID:
22584102
[PubMed - indexed for MEDLINE]
15.

How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?

Jagadeesh G, Balakumar P, Stockbridge N.

Cell Signal. 2012 Aug;24(8):1583-91. doi: 10.1016/j.cellsig.2012.04.003. Epub 2012 Apr 13. Review.

PMID:
22522051
[PubMed - indexed for MEDLINE]
16.

Telmisartan in the management of diabetic nephropathy: a contemporary view.

Balakumar P, Bishnoi HK, Mahadevan N.

Curr Diabetes Rev. 2012 May;8(3):183-90. Review.

PMID:
22429010
[PubMed - indexed for MEDLINE]
17.

Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders.

Balakumar P, Kathuria S.

Br J Pharmacol. 2012 Aug;166(7):1981-92. doi: 10.1111/j.1476-5381.2012.01938.x. Review.

PMID:
22404217
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?

Balakumar P, Kadian S, Mahadevan N.

Pharmacol Res. 2012 Apr;65(4):430-6. doi: 10.1016/j.phrs.2012.01.004. Epub 2012 Jan 21. Review.

PMID:
22285932
[PubMed - indexed for MEDLINE]
19.

PPAR ligands and cardiovascular disorders: friend or foe.

Balakumar P, Jagadeesh G.

Curr Mol Pharmacol. 2012 Jun;5(2):219-23. No abstract available.

PMID:
22122451
[PubMed - indexed for MEDLINE]
20.

Preconditioning the hyperlipidemic myocardium: fact or fantasy?

Balakumar P, Babbar L.

Cell Signal. 2012 Mar;24(3):589-95. doi: 10.1016/j.cellsig.2011.11.003. Epub 2011 Nov 9. Review.

PMID:
22101013
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk